We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Honeywell (HON), Recipharm Unite to Develop Near-Zero GWP pMDIs
Read MoreHide Full Article
Honeywell International Inc. (HON - Free Report) recently partnered with global contract development and manufacturing organization, Recipharm, to accelerate the development of pressurized metered dose inhalers (pMDIs). These pMDIs use HON’s near-zero global warming potential (GWP) propellant Solstice Air.
Many of the patients suffering from chronic obstructive pulmonary disease (COPD) and asthma are advised to use pMDIs containing hydrofluoroalkanes (HFAs) as propellants, which have a high global warming potential. Honeywell Solstice Air uses hydrofluoroolefin propellant which has 99.9% less global warming potential compared to HFAs and is noncombustible, non-ozone-depleting and free from volatile organic compound as well.
This collaboration will allow the two companies to offer low greenhouse gas pMDIs to the patients. Also, the increased use of near-zero GWP propellant in the pMDIs will reduce the harmful effects of these life-saving medical treatments on the environment.
Honeywell has invested more than $1 billion for research and development of the Solstice technology, which is used in refrigerants, blowing agents, aerosols and solvents. The use of this technology has reduced the potential release of 326 million metric tons of carbon dioxide into the air. This agreement between the two companies is aligned with HON’s goal to reduce carbon footprint on the environment.
Zacks Rank & Stocks to Consider
HON currently carries a Zacks Rank #3 (Hold). Some better-ranked companies are discussed below:
CAT’s earnings surprise in the last four quarters was 18.5%, on average. In the past 60 days, estimates for Caterpillar’s earnings have increased 9.5% for 2023. The stock has gained 40.6% in the past year.
A. O. Smith Corp. (AOS - Free Report) presently carries a Zacks Rank #2 (Buy). AOS’ earnings surprise in the last four quarters was 10.5%, on average.
In the past 60 days, estimates for A. O. Smith’s earnings have increased 2.9% for 2023. The stock has gained 11.4% in the past year.
Alamo Group Inc. (ALG - Free Report) presently carries a Zacks Rank of 2.ALG’s earnings surprise in the last four quarters was 13%, on average.
In the past 60 days, estimates for Alamo’s 2023 earnings have increased 1.1%. The stock has gained 24% in the past year.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Honeywell (HON), Recipharm Unite to Develop Near-Zero GWP pMDIs
Honeywell International Inc. (HON - Free Report) recently partnered with global contract development and manufacturing organization, Recipharm, to accelerate the development of pressurized metered dose inhalers (pMDIs). These pMDIs use HON’s near-zero global warming potential (GWP) propellant Solstice Air.
Many of the patients suffering from chronic obstructive pulmonary disease (COPD) and asthma are advised to use pMDIs containing hydrofluoroalkanes (HFAs) as propellants, which have a high global warming potential. Honeywell Solstice Air uses hydrofluoroolefin propellant which has 99.9% less global warming potential compared to HFAs and is noncombustible, non-ozone-depleting and free from volatile organic compound as well.
This collaboration will allow the two companies to offer low greenhouse gas pMDIs to the patients. Also, the increased use of near-zero GWP propellant in the pMDIs will reduce the harmful effects of these life-saving medical treatments on the environment.
Honeywell International Inc. Price
Honeywell International Inc. price | Honeywell International Inc. Quote
Honeywell has invested more than $1 billion for research and development of the Solstice technology, which is used in refrigerants, blowing agents, aerosols and solvents. The use of this technology has reduced the potential release of 326 million metric tons of carbon dioxide into the air. This agreement between the two companies is aligned with HON’s goal to reduce carbon footprint on the environment.
Zacks Rank & Stocks to Consider
HON currently carries a Zacks Rank #3 (Hold). Some better-ranked companies are discussed below:
Caterpillar Inc. (CAT - Free Report) presently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks.
CAT’s earnings surprise in the last four quarters was 18.5%, on average. In the past 60 days, estimates for Caterpillar’s earnings have increased 9.5% for 2023. The stock has gained 40.6% in the past year.
A. O. Smith Corp. (AOS - Free Report) presently carries a Zacks Rank #2 (Buy). AOS’ earnings surprise in the last four quarters was 10.5%, on average.
In the past 60 days, estimates for A. O. Smith’s earnings have increased 2.9% for 2023. The stock has gained 11.4% in the past year.
Alamo Group Inc. (ALG - Free Report) presently carries a Zacks Rank of 2.ALG’s earnings surprise in the last four quarters was 13%, on average.
In the past 60 days, estimates for Alamo’s 2023 earnings have increased 1.1%. The stock has gained 24% in the past year.